This topic contains a solution. Click here to go to the answer

Author Question: In the above figure, the firm is a monopolistically competitive firm. In the long run, its economic ... (Read 35 times)

codyclark

  • Hero Member
  • *****
  • Posts: 538
In the above figure, the firm is a monopolistically competitive firm. In the long run, its economic profit will be
 
  A) zero.
  B) between zero and 50 per day.
  C) greater than 50 per day.
  D) some amount that cannot be determined without more information.

Question 2

In the figure above, the Lorenz curve that shows the least inequality, but NOT perfect equality, is
 
  A) curve A.
  B) curve B.
  C) curve C.
  D) curve D.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vkodali

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

A

Answer to Question 2

B




codyclark

  • Member
  • Posts: 538
Reply 2 on: Jun 29, 2018
Wow, this really help


ultraflyy23

  • Member
  • Posts: 312
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library